SHSantosh Hariharan

Santosh Hariharan

*This is an algorithmically generated author record based on publicly available information.

Santosh Hariharan has a total of 127 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Screening for variable drug responses using human iPSC cohorts

    by Melpomeni Platani, Hao Jiang, Lindsay Davidson, Santosh Hariharan, Regis Doyonnas, Angus I. Lamond, Jason R. Swedlow

    We have developed a laboratory-based drug screening platform that uses a cohort of human induced pluripotent stem cell (hiPSC) lines, derived from different donors, to predict variable drug responses of potential clinical relevance. This builds on recent findings that pluripotent hiPSC lines express a broad repertoire of gene transcripts and proteins, whose expression levels reflect the genetic identity of the donor. We demonstrate that a cohort of hiPSC lines from different donors can be screened efficiently in their pluripotent state, using high-throughput Cell Painting assays. Variable phenotypic responses between hiPSC lines were detected with a wide range of clinically approved drugs, in use across multiple disease areas. Furthermore, information on mechanisms of drug-cell interactions underlying the observed variable responses was derived by using quantitative proteomic analysis to compare sets of hiPSC lines that had been stratified objectively, based upon variable response, Cell Painting data. We propose that information derived from comparative drug screening, using curated libraries of hiPSC lines from different donors, can help to improve the delivery of safe new drugs suitable for a broad range of genetic backgrounds and sexual diversity within human populations.


  • Open Access

    JUMP Cell Painting chemical dataset: Morphological map of 115,796 compounds in human cells

    by Srinivas Niranj Chandrasekaran, Jeanelle Ackerman, Eric Alix, D. Michael Ando, John Arevalo, Melissa Bennion, Nicolas Boisseau, Adriana Borowa, Justin D. Boyd, Laurent Brino, et al.

    Image-based profiling decodes complex cellular states for high-impact biological and therapeutic applications, yet a large, public reference dataset of chemical perturbations has been lacking. We present Cell Painting images and 1.53 billion single-cell profiles for 115,796 compounds in human osteosarcoma cells, generated by the Joint Undertaking for Morphological Profiling (JUMP)-Cell Painting Consortium of 18 industry and non-profit partners. Despite technical variability across 12 data-generating laboratories, more than 15% of compounds show statistically significant phenotypic activity, reproducibility drops only 34% versus single-laboratory data, and compounds sharing biological targets often show similar image-based profiles. JUMP establishes a validated public reference resource that brings image-based profiling on par with genomics and transcriptomics. The dataset, shared alongside previously released genetic perturbation data in the Cell Painting Gallery, is a powerful predictive engine for the impact, mechanism, targets and activities of compounds, fundamentally accelerating chemical and cell biology and early-stage drug development.


  • Open Access

    Optimizing the Cell Painting assay for image-based profiling

    by Beth A. Cimini, Srinivas Niranj Chandrasekaran, Maria Kost-Alimova, Lisa Miller, Amy Goodale, Briana Fritchman, Patrick Byrne, Sakshi Garg, Nasim Jamali, David J. Logan, et al.

    In image-based profiling, software extracts thousands of morphological features of cells from multi-channel fluorescence microscopy images, yielding single-cell profiles that can be used for basic research and drug discovery. Powerful applications have been proven, including clustering chemical and genetic perturbations based on their similar morphological impact, identifying disease phenotypes by observing differences in profiles between healthy and diseased cells, and predicting assay outcomes using machine learning, among many others. Here we provide an updated protocol for the most popular assay for image-based profiling, Cell Painting. Introduced in 2013, it uses six stains imaged in five channels and labels eight diverse components of the cell: DNA, cytoplasmic RNA, nucleoli, actin, Golgi apparatus, plasma membrane, endoplasmic reticulum, and mitochondria. The original protocol was updated in 2016 based on several years’ experience running it at two sites, after optimizing it by visual stain quality. Here we describe the work of the Joint Undertaking for Morphological Profiling (JUMP) Cell Painting Consortium, aiming to improve upon the assay via quantitative optimization, based on the measured ability of the assay to detect morphological phenotypes and group similar perturbations together. We find that the assay gives very robust outputs despite a variety of changes to the protocol and that two vendors’ dyes work equivalently well. We present Cell Painting version 3, in which some steps are simplified and several stain concentrations can be reduced, saving costs. Cell culture and image acquisition take 1–2 weeks for a typically sized batch of 20 or fewer plates; feature extraction and data analysis take an additional 1–2 weeks. Key references using this protocol: Virtual screening for small-molecule pathway regulators by image-profile matching ( https://doi.org/10.1016/j.cels.2022.08.003 ) - recent work examining the ability to use collected Cell Painting profiles to screen for regulators of a number of diverse biological pathways. JUMP Cell Painting dataset: images and profiles from two billion cells perturbed by 140,000 chemical and genetic perturbations (DOI) - the description of the main JUMP master public data set, using this protocol in the production of >200 TB of image data and >200 TB of measured profiles. Key data used in this protocol: Cell Painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes ( https://doi.org/10.1038/nprot.2016.105 ) - this paper provides the first step-by-step Cell Painting protocol ever released.


  • Open Access

    Rapid 3D phenotypic analysis of neurons and organoids using data-driven cell segmentation-free machine learning

    by Philipp Mergenthaler, Santosh Hariharan, James M. Pemberton, Corey Lourenco, Linda Z. Penn, David W. Andrews

    Phenotypic profiling of large three-dimensional microscopy data sets has not been widely adopted due to the challenges posed by cell segmentation and feature selection. The computational demands of automated processing further limit analysis of hard-to-segment images such as of neurons and organoids. Here we describe a comprehensive shallow-learning framework for automated quantitative phenotyping of three-dimensional (3D) image data using unsupervised data-driven voxel-based feature learning, which enables computationally facile classification, clustering and advanced data visualization. We demonstrate the analysis potential on complex 3D images by investigating the phenotypic alterations of: neurons in response to apoptosis-inducing treatments and morphogenesis for oncogene-expressing human mammary gland acinar organoids. Our novel implementation of image analysis algorithms called Phindr3D allowed rapid implementation of data-driven voxel-based feature learning into 3D high content analysis (HCA) operations and constitutes a major practical advance as the computed assignments represent the biology while preserving the heterogeneity of the underlying data. Phindr3D is provided as Matlab code and as a stand-alone program (https://github.com/DWALab/Phindr3D).


  • Open Access

    Image‐Based Analysis of Protein Stability

    by K. Ashley Hickman, Santosh Hariharan, Jason De Melo, Jarkko Ylanko, Lindsay C. Lustig, Linda Z. Penn, David W. Andrews

    Short half‐life proteins regulate many essential processes, including cell cycle, transcription, and apoptosis. However, few well‐characterized protein‐turnover pathways have been identified because traditional methods to measure protein half‐life are time and labor intensive. To overcome this barrier, we developed a protein stability probe and high‐content screening pipeline for novel regulators of short half‐life proteins using automated image analysis. Our pilot probe consists of the short half‐life protein c‐MYC (MYC) fused to Venus fluorescent protein (MYC‐Venus). This probe enables protein half‐life to be scored as a function of fluorescence intensity and distribution. Rapid turnover prevents maximal fluorescence of the probe due to the relatively longer maturation time of the fluorescent protein. Cells expressing the MYC‐Venus probe were analyzed using a pipeline in which automated confocal microscopy and image analyses were used to score MYC‐Venus stability by two strategies: assaying the percentage of cells with Venus fluorescence above background, and phenotypic comparative analysis. To evaluate this high‐content screening pipeline and our probe, a kinase inhibitor library was screened by confocal microscopy to identify known and novel kinases that regulate MYC stability. Compounds identified were shown to increase the half‐life of both MYC‐Venus and endogenous MYC, validating the probe and pipeline. Fusion of another short half‐life protein, myeloid cell leukemia 1 (MCL1), with Venus also demonstrated an increase in percent Venus‐positive cells after treatment with inhibitors known to stabilize MCL1. Together, the results validate the use of our automated microscopy and image analysis pipeline of stability probe‐expressing cells to rapidly and quantitatively identify regulators of short half‐life proteins. © 2019 The Authors. Cytometry Part A published by Wiley Periodicals, Inc. on behalf of International Society for Advancement of Cytometry.


  • Open Access

    Peak emission wavelength and fluorescence lifetime are coupled in far-red, GFP-like fluorescent proteins

    by Laura Canty, Santosh Hariharan, Qian Liu, Steven A Haney, David W Andrews

    The discovery and use of fluorescent proteins revolutionized cell biology by allowing the visualization of proteins in living cells. Advances in fluorescent proteins, primarily through genetic engineering, have enabled more advanced analyses, including Förster resonance energy transfer (FRET) and fluorescence lifetime imaging microscopy (FLIM) and the development of genetically encoded fluorescent biosensors. These fluorescence protein-based sensors are highly effective in cells grown in monolayer cultures. However, it is often desirable to use more complex models including tissue explants, organoids, xenografts, and whole animals. These types of samples have poor light penetration owing to high scattering and absorption of light by tissue. Far-red light with a wavelength between 650-900nm is less prone to scatter, and absorption by tissues and can thus penetrate more deeply. Unfortunately, there are few fluorescent proteins in this region of the spectrum, and they have sub-optimal fluorescent properties including low brightness and short fluorescence lifetimes. Understanding the relationships between the amino-acid sequences of far-red fluorescence proteins and their photophysical properties including peak emission wavelengths and fluorescence lifetimes would be useful in the design of new fluorescence proteins for this region of the spectrum. We used both site-directed mutagenesis and gene-shuffling between mScarlet and mCardinal fluorescence proteins to create new variants and assess their properties systematically. We discovered that for far-red, GFP-like proteins the emission maxima and fluorescence lifetime have a strong inverse correlation.